JOSÉ JAVIER
FERNÁNDEZ RUIZ
Catedrático de universidad
Publicacións nas que colabora con JOSÉ JAVIER FERNÁNDEZ RUIZ (51)
2017
-
Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3
PLoS ONE, Vol. 12, Núm. 4
-
Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies
Methods in Enzymology (Academic Press Inc.), pp. 175-198
2016
2014
-
Cannabinoids and the brain: New hopes for new therapies
Cannabinoids (John Wiley and Sons Ltd), pp. 175-218
-
Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias
British Journal of Pharmacology, Vol. 171, Núm. 6, pp. 1472-1489
-
Combining rimonabant and fentanyl in a single entity: Preparation and pharmacological results
Drug Design, Development and Therapy, Vol. 8, pp. 263-277
-
Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias
Pathobiology, Vol. 81, Núm. 3, pp. 149-159
2013
-
Description of a bivalent cannabinoid ligand with hypophagic properties
Archiv der Pharmazie, Vol. 346, Núm. 3, pp. 171-179
-
Design and synthesis of novel cannabinoid ligands based on a 1,2,3-triazole scaffold
Letters in Drug Design and Discovery, Vol. 10, Núm. 2, pp. 169-172
-
Novel antiobesity agents: Synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21
Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 7, pp. 1708-1716
2012
-
Chromenopyrazoles: Non-psychoactive and Selective CB 1 Cannabinoid Agonists with Peripheral Antinociceptive Properties
ChemMedChem, Vol. 7, Núm. 3, pp. 452-463
2010
-
Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders
CNS Neuroscience and Therapeutics, Vol. 16, Núm. 3
-
The endocannabinoid system as a target for the treatment of neuronal damage
Expert Opinion on Therapeutic Targets, Vol. 14, Núm. 4, pp. 387-404
2009
-
Cannabinoids, multiple sclerosis and neuroprotection
Expert Review of Clinical Pharmacology, Vol. 2, Núm. 6, pp. 645-660
2008
-
Cannabinoid signaling system: does it play a function in cell proliferation and migration, neuritic elongation and guidance and synaptogenesis during brain ontogenesis?
Cell adhesion & migration, Vol. 2, Núm. 4, pp. 246-248
-
Colocalization of CB1 receptors with L1 and GAP-43 in forebrain white matter regions during fetal rat brain development: Evidence for a role of these receptors in axonal growth and guidance
Neuroscience, Vol. 153, Núm. 3, pp. 687-699
2007
-
The activation of cannabinoid receptors during early postnatal development reduces the expression of cell adhesion molecule L1 in the rat brain
Brain Research, Vol. 1145, Núm. 1, pp. 48-55
2005
-
Therapeutic potential of the endocannabinoid system in the brain
Mini-Reviews in Medicinal Chemistry, Vol. 5, Núm. 7, pp. 609-617
2004
-
Behavioral and molecular changes elicited by acute administration of SR141716 to Δ
9
-tetrahydrocannabinol-tolerant rats: An experimental model of cannabinoid abstinence
Drug and Alcohol Dependence, Vol. 74, Núm. 2, pp. 159-170
-
Cannabinoids and gene expression during brain development
Neurotoxicity Research, Vol. 6, Núm. 5, pp. 389-401